Accession #:
Independent testing record for Accession #:: 35 third-party lab reports across 17 compounds, tested by 1 analytical laboratories. Built entirely from certificates submitted to ResearchVerify — the vendor has no input into this page.
Total COAs
35
Compounds
17
Testing Labs
1
Avg RV Score
—
Purity Range
99.0%–100.0%
NAD+ (batch Dark Blue Cap) tested at 99.02 by Freedom Diagnostics. Shown for completeness — every batch on file is counted here, not only the strongest results.
Purity Tier Distribution
26
Tier 1 (≥99.5%)
9
Tier 2 (≥98.5%)
0
Tier 3 (≥95%)
0
Tier 4 (<95%)
Recent Tests
- NAD+ · Freedom Diagnostics · · RV —/10 · — · #2607010570
- Retatrutide · Freedom Diagnostics · · RV —/10 · — · #2607010572
- Retatrutide · Freedom Diagnostics · · RV —/10 · — · #2607010574
- Retatrutide · Freedom Diagnostics · · RV —/10 · — · #2607010576
- TB-500 · Freedom Diagnostics · · RV —/10 · — · #2607010578
- KPV · Freedom Diagnostics · · RV —/10 · — · #2607010580
- Tesamorelin · Freedom Diagnostics · · RV —/10 · — · #2607010582
- Semax · Freedom Diagnostics · · RV —/10 · — · #2607010584
- SS-31 · Freedom Diagnostics · · RV —/10 · — · #2607010586
- BPC-157 · Freedom Diagnostics · · RV —/10 · — · #2607010588
- Selank · Freedom Diagnostics · · RV —/10 · — · #2607010590
- Ipamorelin · Freedom Diagnostics · · RV —/10 · — · #2607010592
- MOTS-C · Freedom Diagnostics · · RV —/10 · — · #2607010594
- MOTS-C · Freedom Diagnostics · · RV —/10 · — · #2607010596
- Tirzepatide · Freedom Diagnostics · · RV —/10 · — · #2607010598
Compounds Tested
- Tirzepatide · 9 tests
- Retatrutide · 4 tests
- GHK-Cu · 3 tests
- NAD+ · 2 tests
- Tesamorelin · 2 tests
- MOTS-C · 2 tests
- MOTS-c · 2 tests
- Cagrilintide · 2 tests
- TB-500 · 1 tests
- KPV · 1 tests
- Semax · 1 tests
- SS-31 · 1 tests
Testing Labs
- Freedom Diagnostics · 35 tests
This page is generated automatically from independently-submitted certificates of analysis. ResearchVerify is not affiliated with Accession #:. Vendors cannot pay to appear here, alter their results, or have this page removed.